ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.395
0.00%
US Dollar vs AUD
1.51745
0.00%
Bitcoin
69,395.36
0.09%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Invivyd Inc (IVVD)

  7. Invivyd Inc (IVVD) News

IVVD

Invivyd (IVVD)

Invivyd Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IVVD
DateTimeSourceHeadlineSymbolCompany
07/06/202406:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
07/06/202406:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
04/06/202406:01GlobeNewswire Inc.Invivyd to Participate at the Jefferies Global Healthcare ConferenceNASDAQ:IVVDInvivyd Inc
31/05/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
31/05/202421:05GlobeNewswire Inc.Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for SerialNASDAQ:IVVDInvivyd Inc
31/05/202421:00GlobeNewswire Inc.Invivyd Announces the Appointment of Timothy Lee as Chief Commercial OfficerNASDAQ:IVVDInvivyd Inc
29/05/202421:00GlobeNewswire Inc.Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)NASDAQ:IVVDInvivyd Inc
24/05/202408:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
24/05/202408:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
24/05/202407:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
24/05/202406:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
24/05/202406:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
22/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
22/05/202421:00GlobeNewswire Inc.Invivyd Elects Two New Independent Members to its Board of DirectorsNASDAQ:IVVDInvivyd Inc
17/05/202406:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IVVDInvivyd Inc
14/05/202406:01GlobeNewswire Inc.Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:IVVDInvivyd Inc
10/05/202406:32Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IVVDInvivyd Inc
10/05/202406:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IVVDInvivyd Inc
10/05/202406:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
10/05/202406:01GlobeNewswire Inc.Invivyd Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
07/05/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
07/05/202421:30GlobeNewswire Inc.Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA FeedbackNASDAQ:IVVDInvivyd Inc
03/05/202407:13GlobeNewswire Inc.Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business HighlightsNASDAQ:IVVDInvivyd Inc
30/04/202421:30GlobeNewswire Inc.Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash PositionNASDAQ:IVVDInvivyd Inc
15/04/202421:30GlobeNewswire Inc.Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™NASDAQ:IVVDInvivyd Inc
12/04/202421:30GlobeNewswire Inc.Invivyd Announces CEO TransitionNASDAQ:IVVDInvivyd Inc
05/04/202407:01GlobeNewswire Inc.Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 MillionNASDAQ:IVVDInvivyd Inc
28/03/202422:00GlobeNewswire Inc.Invivyd Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
23/03/202406:28GlobeNewswire Inc.Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical TrialNASDAQ:IVVDInvivyd Inc
23/03/202406:04GlobeNewswire Inc.Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19NASDAQ:IVVDInvivyd Inc
 Showing the most relevant articles for your search:NASDAQ:IVVD

Your Recent History

COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
FX
GBPAUD
Sterling vs AUD
ASX
BHP
BHP
NYSE
NKE
Nike
ASX
WDC
Westfield
ASX
XJO
S&P ASX 200
ASX
FMG
Fortescue
ASX
CSL
CSL
ASX
WPL
Woodside Petroleum
FX
AUDUSD
AUD vs US Dollar
NASDAQ
AMZN
Amazon.com
ASX
ANZ
Australia And New Zealan...
FX
AUDJPY
AUD vs Yen
ASX
XMM
S&P ASX 300 Metals and M...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved